Evaluation of the Pharmacokinetic Features and Tissue Distribution of the Potent Nonnucleoside Inhibitor of HIV-1 Reverse Transcriptase, N-[2-(2-fluorophenethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-240) with an Analytical HPLC Method

@article{Chen2004EvaluationOT,
  title={Evaluation of the Pharmacokinetic Features and Tissue Distribution of the Potent Nonnucleoside Inhibitor of HIV-1 Reverse Transcriptase, N-[2-(2-fluorophenethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-240) with an Analytical HPLC Method},
  author={C. Chen and F. Uckun},
  journal={Pharmaceutical Research},
  year={2004},
  volume={16},
  pages={1226-1232}
}
  • C. Chen, F. Uckun
  • Published 2004
  • Medicine, Chemistry
  • Pharmaceutical Research
    • AbstractPurpose. The purpose of the present study was to examine the pharmacokinetic features and tissue distribution of N-[2-(2-fluorophenethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-240), a novel non-nucleoside inhibitor of HIV reverse transcriptase with potent anti-viral activity against AZT-sensitive as well as multidrug-resistant HIV-1 strains. Methods. A sensitive and accurate high performance liquid chromatography (HPLC)-based quantitative detection method was established to measure… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    7 Citations
    Background Citations
    1
    Methods Citations
    1
    7 Citations
    Citation Type

    Citation Type

    In Vivo Pharmacokinetic Features, Toxicity Profile, and Chemosensitizing Activity of α-Cyano-β-hydroxy-β- methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), a Novel Antileukemic Agent Targeting Bruton’s Tyrosine Kinase
    • 30
    A 13-Week Subchronic Intravaginal Toxicity Study of the Novel Broad-Spectrum Anti-HIV and Spermicidal Agent, N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (PHI-346) in Mice
    • 6
    Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase
    • O. D'cruz, F. Uckun
    • Biology, Medicine
    • Journal of enzyme inhibition and medicinal chemistry
    • 2006
    • 22
    Effect of stereo and regiochemistry towards wild and multidrug resistant HIV-1 virus: viral potency of chiral PETT derivatives.
    • 17
    Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds.
    • 112
    Dawn of non-nucleoside inhibitor-based anti-HIV microbicides.
    • 96
    • PDF
    Structural Requirements for Potent Anti-Human Immunodeficiency Virus (HIV) and Sperm-Immobilizing Activities of Cyclohexenyl Thiourea and Urea Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase1
    • 20
    • PDF

    References

    SHOWING 1-10 OF 10 REFERENCES
    Pharmacokinetics and Biologic Activity of the Novel Mast Cell Inhibitor, 4-(3′-Hydroxyphenyl)-amino-6,7-dimethoxyquinazoline in Mice
    • 10
    The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection
    • 264
    The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    • 82
    • PDF
    Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    • 52
    Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase
    • 76
    Non-nucleoside inhibitors of HIV-1 reverse transcriptase
    • 39
    Quantitative high-performance liquid chromatography-based detection method for calphostin C, a naturally occurring perylenequinone with potent antileukemic activity.
    • 10
    Tissue distribution and metabolic disposition of zidovudine in rats.
    • 40
    A TOXICOLOGIC STUDY OF DIMETHYL SULFOXIDE.
    • 84
    Physiological Parameters in Laboratory Animals and Humans
    • 2,178